ARQT
Arcutis Biotherapeutics, Inc.
NASDAQ · Healthcare · Biotechnology · US
$25.38
−4.08%Forward multiples
Based on analyst estimates
- P/E forward
- 31.48x
- P/E 2026E
- 51.40x
- P/E 2027E
- 19.28x
- P/E 2028E
- 12.20x
- P/S forward
- 5.29x
Trailing multiples
Trailing twelve months
- P/E TTM
- 114.95x
- PEG TTM
- 0.44x
- Price / book
- 14.46x
- Price / sales
- 6.88x
- Price / cash flow
- 81.15x
Enterprise value
- Enterprise value
- $3.1B
- EV / sales
- 6.61x
- EV / EBITDA
- 69.47x
- EV / EBIT
- 89.50x
- Market cap
- $3.2B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026